Chellamuthu S, Smith AM, Thomas SM, Hill C, Brown PWG, Al-Mohammad A. Is cardiac MRI an effective test for arrhythmogenic right ventricular cardiomyopathy diagnosis? World J Cardiol 2014; 6(7): 675-681 [PMID: 25068028 DOI: 10.4330/wjc.v6.i7.675]
Corresponding Author of This Article
Dr. Alyson M Smith, Department of Cardiology, Sheffield Teaching Hospitals NHS Trust, Northern General Hospital, Herries Road, Sheffield S5 7AU, United Kingdom. smith_alyson@hotmail.com
Research Domain of This Article
Cardiac & Cardiovascular Systems
Article-Type of This Article
Retrospective Study
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Cardiol. Jul 26, 2014; 6(7): 675-681 Published online Jul 26, 2014. doi: 10.4330/wjc.v6.i7.675
Table 1 Task force criteria for the diagnosis of arrhythmogenic right ventricular cardiomyopathy[19]
1 Global and/or regional dysfunction and structural alterations (detected by echocardiography, angiography, magnetic resonance imaging, or radionuclide scintigraphy)
Major: Severe dilatation and reduction of right ventricular ejection fraction with no (or only mild) left ventricular impairment. Localized right ventricular aneurysms (akinetic or dyskinetic areas with diastolic bulging). Severe segmental dilatation of the right ventricle
Minor: Mild global right ventricular dilatation and/or ejection fraction reduction with normal left ventricle Mild segmental dilatation of the right ventricle Regional right ventricular hypokinesia
2 Tissue characterization of wall
Major: Fibro-fatty replacement of myocardium on endomyocardial biopsy
3 Repolarisation Abnormalities
Minor: Inverted T waves in right precordial leads (V2 and V3) in people aged > 12 yr, in absence of right bundle branch block
4 Depolarization/conduction abnormalities
Major: Epsilon waves or localized prolongation (> 110 ms) of the QRS complex in right precordial leads (V1-V3)
Minor: Late potentials (signal-averaged ECG)
5 Arrhythmias
Minor: Left bundle branch block type ventricular tachycardia (sustained and non-sustained) by ECG, Holter or exercise testing. Frequent ventricular extra-systoles (> 1000/24 h) by Holter
6 Family history
Major: Familial disease confirmed at necropsy or surgery
Minor: Family history of premature sudden death (< 35 yr) due to suspected right ventricular dysplasia. Familial history (clinical diagnosis based on present criteria)
Table 2 Revised task force criteria for imaging[5]
Major
By 2D echo:
Regional RV akinesia, dyskinesia or aneurysm and one of the following (end diastole):
1 Parasternal long axis view RVOT (PLAX) ≥ 32 mm (corrected for body size (PLAX/BSA) ≥ 19 mm/m2)
2 Parasternal short axis view RVOT (PSAX) ≥ 36 mm (corrected for body size (PSAX/BSA) ≥ 21 mm/m2)
3 Or fractional area change (FAC) ≤ 33%
By MRI:
Regional RV akinesia or dyskinesia or dyssynchronous RV contraction and one of the following:
1 Right ventricular end diastolic volume (RVEDV/BSA) ≥ 110 mL/m2 (male) or ≥ 100 mL/m2 (female)
2 Or RVEF ≤ 40%
By RV angiography:
Regional RV akinesia, dyskinesia or aneurysm
Minor
By 2D echo Regional RV akinesia or dyskinesia and one of the following (end diastole):
1 Parasternal long axis view RVOT (PLAX) ≥ 29 - < 32 mm (corrected for body size (PLAX/BSA) ≥ 16 - < 19 mm/m2)
2 Parasternal short axis view RVOT (PSAX) ≥ 32 - < 36 mm (corrected for body size(PSAX/BSA) ≥ 18 - < 21 mm/m2)
3 Or FAC > 33% - ≤ 40%
By MRI Regional RV akinesia or dyskinesia or dyssynchronous RV contraction and one of the following:
1 Right ventricular end diastolic volume/BSA ≥ 100 - < 110 mL/m2 (male) or ≥ 90 - < 100 mL/m2 (female)
Minor and non specific criteria for ARVC (not clinically proven)
3
Normal
15
LV hypertrophy
1
LV dyssynchrony
1
LV infarct
1
Dilated cardiomyopathy
1
Table 5 Positive predictive value in different groups
Clinical history - No ofpatients
Major criteria present
Clinically proven ARVC
Positive predictive value
Minor criteria present
Clinically proven ARVC
Positive predictive value
Arrhythmia (30%)
2
1
50%
3
2
67%
Family history of SCD (20%)
1
1
100%
1
0
0%
Others (50%)
1
1
100%
9
0
0%
Citation: Chellamuthu S, Smith AM, Thomas SM, Hill C, Brown PWG, Al-Mohammad A. Is cardiac MRI an effective test for arrhythmogenic right ventricular cardiomyopathy diagnosis? World J Cardiol 2014; 6(7): 675-681